Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021

ラットモデルの世界市場予測(~2021):モデル種類別(非近交系、近交系、ノックアウト)、技術別、治療分野別、サービス別、ケア製品別、需要先別

◆タイトル:Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021
◆商品コード:MAM-BT-3682
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年1月12日
◆ページ数:256
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ラットモデルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、モデル種類別分析、技術別分析、治療分野別分析、サービス別分析、ラットモデルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global rat model market is projected to reach USD 588.9 Million by 2021 from 387.7 Million in 2016, growing at a CAGR of 8.7% during the forecast period. Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the market. In addition to this, increase in R&D activities in pharmaceutical industries is further stimulating the market growth.
The global market is categorized on the basis of model type, service, therapeutic area, technology, end user, care product, and region. On the basis of model type, the market is categorized into outbred rat, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global market. However, the knockout/genetically modified rats segment is expected to be the fastest-growing segment owing to the use of this type of rat models to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s disease.

In 2016, the breeding services segment is expected to command the largest share of the market, by services. However, the cryopreservation services segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the fact that cryopreservation services help in obtaining the genetic material of rats even after the reproductive lifespan of these rats. This cuts down the time and cost needed for regenerating the rat models. In 2016, the CRISPR segment is expected to command the largest share of the global market, by technology. The large share of this segment can be attributed to its ease of use and ability to multiply.

On the basis of therapeutic area, the market is segmented into toxicology, oncology, immunology & inflammation, diabetes, neurology, and other therapeutic areas (rare diseases, cardiovascular diseases, metabolic diseases, hematopoiesis, and renal disorders). In 2016, the toxicology segment is expected to command the largest share of the global market.

On the basis of end user, the rat model market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and contract research organizations (CROs). In 2016, the pharmaceutical & biotechnology companies segment is expected to command the largest share of the global market. However, the academic & research institutions segment is expected to grow at the highest CAGR during the forecast period.

On the basis of care product, the market is segmented into bedding, cages, feed, and other products (gnotobiotic equipment, water systems, water purification systems, and sound absorption panels). In 2016, the cages segment is expected to command the largest share of the market.

In 2016, North America is expected to account for the largest share of the global rat model market. North America’s leadership in this market can be attributed to the revised funding plans by NIH to enhance reproducibility of results, rising demands for monoclonal antibody production, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada. In the coming years, the rat models market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to less stringent regulations on the use of animal models for research in the region, international alliances for R&D activities in China, growth in regenerative medicine, biomedical, and medical research in Japan, growing presence of global players, development of bioclusters to boost biotechnology industry in India, ongoing biomedical research activities in Australia, and rising pharmaceutical and biotechnology R&D activities.

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Research Methodology
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 35)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 43)
4.1 Rat Model Market Overview
4.2 Regional Analysis: Global Rat Care Product Market, By Type
4.3 Global Rat Model Market, By Therapeutic Area, 2016 & 2021
4.4 Regional Snapshot of the Global Rat Model Market

5 Market Overview (Page No. – 46)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in Gene Editing Tools Set to Augment the Demand for Rat Models
5.2.1.2 Advantages Offered By Rats Over Mice
5.2.1.3 Continuous Support in the Form of Investments and Grants
5.2.1.4 Increased Demand for Personalized Humanized Rat Models Due to Growing Consumption of Personalized Medicines
5.2.1.5 Increase in R&D Activities Carried Out By Pharmaceutical and Biotechnology Companies
5.2.2 Restraints
5.2.2.1 Regulations & Laws Formulated for Ethical Use of Animals
5.2.2.1.1 the Animal Welfare Act (AWA)
5.2.2.1.2 Public Health Service Policy (PHS) on Humane Care and Use of Laboratory Animals
5.2.2.2 Increased Benefits Offered By Cryopreservation
5.2.3 Opportunities
5.2.3.1 Increased Production of Monoclonal Antibodies
5.2.3.2 Rising Demand of Humanized Rat Models
5.2.4 Challenges
5.2.4.1 Advancements in Zebrafish Model Development
5.2.4.2 Development of Methods Alternative to Animal Testing

6 Clinical Trials & Research Studies Assessment (Page No. – 56)
6.1 Introduction
6.2 Clinical Trials
6.3 Research Studies

7 Global Rat Model Market, By Model Type (Page No. – 65)
7.1 Introduction
7.2 Outbred Rats
7.3 Inbred Rats
7.4 Knockout/Genetically Engineered Rats
7.5 Hybrid/Congenic Rats
7.6 Conditioned/Surgically Modified Rats
7.7 Immunodeficient Rats

8 Global Rat Model Market, By Service (Page No. – 74)
8.1 Introduction
8.2 Breeding
8.3 Cryopreservation
8.4 Quarantine
8.5 Rederivation
8.6 Model In-Licensing
8.7 Genetic Testing
8.8 Others
8.8.1 Surgical Services
8.8.2 Line Rescue Services
8.8.3 In Vivo Pharmacology Services

9 Global Rat Model Market, By Technology (Page No. – 85)
9.1 Introduction
9.2 Crispr
9.3 Microinjection
9.4 Embryonic Stem Cell Injection
9.5 Nuclear Transfer
9.6 Other Technologies

10 Global Rat Model Market, By Therapeutic Area (Page No. – 94)
10.1 Introduction
10.2 Toxicology
10.3 Oncology
10.3.1 New Product Launches for Oncology Research
10.3.2 Continuous Grants/Funds to Support Cancer Research Studies
10.4 Immunology and Inflammation
10.5 Neurology
10.6 Diabetes
10.7 Others

11 Global Rat Model Market, By End User (Page No. – 106)
11.1 Introduction
11.2 Pharmaceutical & Biotechnology Companies
11.3 Academic & Research Institutions
11.4 Contract Research Organizations (CRO)

12 Global Rat Model Market, By Care Product (Page No. – 112)
12.1 Introduction
12.2 Cages
12.3 Feed
12.4 Bedding
12.5 Other Care Products

13 Global Rat Model Market, By Region (Page No. – 119)
13.1 Introduction
13.2 North America
13.2.1 U.S.
13.2.1.1 Growing Biomedical Research in the U.S.
13.2.1.2 Preclinical Activities By Cros and Pharmaceutical R&D
13.2.1.3 Continued and Responsible Use of Animals Ensured By Animal Care Organizations
13.2.1.4 Development of Biosimilars Product Boosting the Demand for Preclinical Services
13.2.1.5 Monoclonal Antibody Production to Augment the Use of Rat Models
13.2.1.6 Partnership Between Cros and Pharmaceutical Companies
13.2.2 Canada
13.2.2.1 Growing Stem Cell Research Activities in Canada
13.2.2.2 Government Support for Development of Protein Drugs is Expected to Drive the Market
13.3 Europe
13.3.1 Germany
13.3.1.1 Launch of Pro-Test Deutschland
13.3.1.2 Flourishing Biotechnology Industry
13.3.2 U.K.
13.3.2.1 Investors Demand Strong Statistics for Animal Studies in the U.K.
13.3.2.2 Increase in Cell Therapy Preclinical Research
13.3.3 France
13.3.3.1 Funding for Rare Disease Projects in France
13.3.4 Russia
13.3.4.1 Growing Biomedical Industry in Russia
13.3.5 Rest of Europe
13.3.5.1 Growth in Biotech and Pharma Sector of Italy
13.3.5.2 Growing Investments in Research By Sweden & Denmark
13.3.5.3 Focus on Rare Disease Research Projects
13.3.5.4 Growth in Biosimilars Market to Lead to Increased Preclinical Activities
13.4 Asia-Pacific
13.4.1 China
13.4.1.1 International Alliances for R&D Activities in China
13.4.1.2 Initiatives to Reduce Longer Approval Times
13.4.1.3 Intellectual Property (Ip) Breaches, A Challenge for the China Market
13.4.1.4 Mandatory Animal Testing for All Pharmaceutical Drugs and Cosmetics in China
13.4.1.5 Increasing Investments From Government and Private Sectors in China’s Life Sciences Sector
13.4.2 Japan
13.4.2.1 Growth in Biomedical and Medical Research in Japan
13.4.2.2 Research in Regenerative Medicine
13.4.2.3 Focus on Cancer Research and Treatment
13.4.3 India
13.4.3.1 Growth of the Pharmaceutical Industry in India
13.4.3.2 Development of Bio-Clusters to Boost India’s Biotechnology
13.4.3.3 Growing Presence of Global Players
13.4.3.4 Shift of Outsourcing Preclinical Activities From India to European Nations
13.4.3.5 Weak Intellectual Property Environment in India
13.4.3.6 Limited Infrastructural Facilities in India, A Major Hindrance for Growth of the Rat Model Market
13.4.4 Rest of Asia-Pacific
13.4.4.1 Ongoing Biomedical Research Activities in Australia to Strengthen the Market
13.4.4.2 Growth in Translational and Biomedical Research in Singapore
13.4.4.3 Increase in Animal Research in Malaysia
13.4.4.4 Government Support for Strong Academic and Commercial R&D Activities in Taiwan
13.4.4.5 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
13.5 Rest of the World
13.5.1 Pharmaceutical, Biotechnology, and Research Industries in Brazil to Drive Market Growth
13.5.2 Favorable Business Environment for Pharmaceutical and Biotechnology Industries in Saudi Arabia and the UAE
13.5.3 Increasing Investments in Mexico

14 Competitive Landscape (Page No. – 194)
14.1 Overview
14.2 Market Share Analysis
14.2.1 Introduction
14.2.2 Charles River Laboratories International, Inc. (U.S.)
14.2.3 Envigo (U.K.)
14.2.4 Taconic Biosciences, Inc. (U.S.)
14.3 Competitive Situation and Trends
14.4 Agreements, Collaborations, and Partnerships
14.5 Acquisitions
14.6 Expansions
14.7 New Product Launches
14.8 Other Strategies

15 Company Profiles (Page No. – 206)
(Overview, Products and Services, Financials, Strategy & Development)*
15.1 Introduction
15.2 Charles River Laboratories International, Inc.
15.3 Taconic Biosciences, Inc.
15.4 Envigo
15.5 Laboratory Corporation of America Holdings
15.6 Janvier Labs
15.7 Genoway S.A.
15.8 Biomere
15.9 Transposagen Biopharmaceuticals, Inc.
15.10 Horizon Discovery Group PLC
15.11 Transviragen, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

16 Appendix (Page No. – 237)
16.1 Discussion Guide
16.2 Other Developments
16.2.1 Charles River Laboratories International, Inc.
16.2.2 Taconic Biosciences, Inc.
16.2.3 Envigo
16.2.4 Laboratory Corporation of America Holdings
16.2.5 Genoway S.A.
16.2.6 Horizon Discovery Group PLC
16.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
16.4 Introducing RT: Real-Time Market Intelligence
16.5 Available Customizations
16.6 Related Reports
16.7 Author Details

List of Tables (132 Tables)

Table 1 Indicative List of Clinical Trials Conducted on Rat Models
Table 2 Indicative List of Research Studies Conducted on Rat Models
Table 3 Global Rat Model Market, By Model Type, 2014-2021 (USD Million)
Table 4 Market for Outbred Rats, By Region, 2014-2021 (USD Thousand)
Table 5 Market for Inbred Rats, By Region, 2014-2021 (USD Thousand)
Table 6 Market for Knockout/Genetically Engineered Rats, By Region, 2014-2021 (USD Thousand)
Table 7 Market for Hybrid/Congenic Rats, By Region, 2013-2021 (USD Thousand)
Table 8 Market for Conditioned/Surgically Modified Rats, By Region, 2013-2021 (USD Thousand)
Table 9 Market for Immunodeficient Rats, By Region, 2013-2021 (USD Thousand)
Table 10 Global Market, By Service, 2014-2021 (USD Million)
Table 11 Market for Breeding, By Region, 2014-2021 (USD Thousand)
Table 12 Market for Cryopreservation, By Region, 2014-2021 (USD Thousand)
Table 13 Market for Quarantine, By Region, 2014-2021 (USD Thousand)
Table 14 Market for Rederivation, By Region, 2014-2021 (USD Thousand)
Table 15 Market for Model In-Licensing, By Region, 2014-2021 (USD Thousand)
Table 16 Market for Genetic Testing, By Region, 2014-2021 (USD Thousand)
Table 17 Market for Others , By Region, 2014-2021 (USD Thousand)
Table 18 Global Market, By Technology, 2014-2021 (USD Million)
Table 19 Market for Crispr, By Region, 2014-2021 (USD Thousand)
Table 20 Market for Microinjection, By Region, 2014-2021 (USD Thousand)
Table 21 Market for Embryonic Stem Cell Injection, By Region, 2014-2021 (USD Thousand)
Table 22 Market for Nuclear Transfer, By Region, 2014-2021 (USD Thousand)
Table 23 Market for Other Technologies, By Region, 2014-2021 (USD Thousand)
Table 24 Global Market, By Therapeutic Area, 2014-2021 (USD Million)
Table 25 Market in Toxicology, By Region, 2014-2021 (USD Thousand)
Table 26 List of Cancer Research Studies Using Rat Models
Table 27 Market in Oncology, By Region, 2013-2021 (USD Thousand)
Table 28 Market in Immunology and Inflammation, By Region, 2014-2021 (USD Thousand)
Table 29 Indicative List of Neurological Research Studies Using Rat Model
Table 30 Market in Neurology, By Region, 2014-2021 (USD Thousand)
Table 31 Market in Diabetes, By Region, 2014-2021 (USD Thousand)
Table 32 Market in Others, By Region, 2014-2021 (USD Thousand)
Table 33 Global Market, By End User, 2014-2021 (USD Million)
Table 34 Market for Pharmaceutical & Biotechnology Companies, By Region, 2014-2021 (USD Thousand)
Table 35 Market for Academic & Research Institutions, By Region, 2014-2021 (USD Thousand)
Table 36 Market for Contract Research Organizations, By Region, 2014-2021 (USD Thousand)
Table 37 Global Rat Care Product Market, By Type, 2014-2021 (USD Thousand)
Table 38 Rat Care Product Market for Cages, By Region, 2014-2021 (USD Thousand)
Table 39 Rat Care Product Market for Feed, By Region, 2014-2021 (USD Thousand)
Table 40 Rat Care Product Market for Bedding, By Region, 2014-2021 (USD Thousand)
Table 41 Rat Care Product Market for Other Care Products, By Region, 2014-2021 (USD Thousand)
Table 42 Market, By Region, 2014–2021 (USD Million)
Table 43 North America: Market, By Country, 2014–2021 (USD Million)
Table 44 North America: Market, By Model Type, 2014–2021 (USD Million)
Table 45 North America: Market, By Service, 2014–2021 (USD Thousand)
Table 46 North America: Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 47 North America: Market, By Technology, 2014–2021 (USD Thousand)
Table 48 North America: Market, By End User, 2014–2021 (USD Million)
Table 49 North America: Rat Care Product Market, By Care Product, 2014–2021 (USD Thousand)
Table 50 Nih Funding for Projects Related to Animal Models
Table 51 Associations Directly Related to the Animal Model Market
Table 52 Associations Indirectly Related to the Animal Model Market
Table 53 U.S.: Market, By Model Type, 2014–2021 (USD Million)
Table 54 U.S.: Market, By Service, 2014–2021 (USD Million)
Table 55 U.S.: Market, By Therapeutic Area, 2014–2021 (USD Million)
Table 56 U.S.: Market, By Technology, 2014–2021 (USD Thousand)
Table 57 U.S.: Market, By End User, 2014–2021 (USD Million)
Table 58 Canada: Market, By Model Type, 2014–2021 (USD Thousand)
Table 59 Canada: Market, By Service, 2014–2021 (USD Thousand)
Table 60 Canada: Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 61 Canada: Market, By Technology, 2014–2021 (USD Thousand)
Table 62 Canada: Market, By End User, 2014–2021 (USD Thousand)
Table 63 Europe: Market, By Country, 2014–2021 (USD Thousand)
Table 64 Europe: Market, By Model Type, 2014–2021 (USD Million)
Table 65 Europe: Market, By Service, 2014–2021 (USD Thousand)
Table 66 Europe: Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 67 Europe: Market, By Technology, 2014–2021 (USD Thousand)
Table 68 Europe: Market, By End User, 2014–2021 (USD Million)
Table 69 Europe: Rat Care Product Market, By Care Product, 2014–2021 (USD Thousand)
Table 70 Germany: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 71 Germany: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 72 Germany: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 73 Germany: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 74 Germany: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 75 U.K.: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 76 U.K.: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 77 U.K.: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 78 U.K.: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 79 U.K.: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 80 France: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 81 France: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 82 France: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 83 France: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 84 France: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 85 Russia: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 86 Russia: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 87 Russia: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 88 Russia: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 89 Russia: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 90 RoE: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 91 RoE: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 92 RoE: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 93 RoE: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 94 RoE: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 95 Asia-Pacific: Rat Model Market, By Country, 2014–2021 (USD Million)
Table 96 Asia-Pacific: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 97 Asia-Pacific: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 98 Asia-Pacific: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 99 Asia-Pacific: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 100 Asia-Pacific: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 101 Asia-Pacific: Rat Care Products Market, By Care Product, 2014–2021 (USD Thousand)
Table 102 China: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 103 China: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 104 China: Rat Model Market Size, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 105 China: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 106 China: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 107 Japan: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 108 Japan: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 109 Japan.: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 110 Japan: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 111 Japan: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 112 India: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 113 India: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 114 India: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 115 India: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 116 India: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 117 Rest of APAC: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 118 Rest of APAC: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 119 Rest of APAC: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 120 Rest of APAC: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 121 Rest of APAC: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 122 RoW: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 123 RoW: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 124 RoW: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 125 RoW: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 126 RoW: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 127 RoW: Rat Care Product Market, By Care Product, 2014–2021 (USD Thousand)
Table 128 Agreements, Collaborations, and Partnerships, 2013–2016
Table 129 Acquisitions, 2013–2016
Table 130 Expansions, 2013–2016
Table 131 New Product Launches, 2013–2016
Table 132 Other Strategies, 2013–2016

List of Figures (47 Figures)

Figure 1 Global Rat Model Market: Research Methodology
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 Global Rat Model Market, By Therapeutic Area (2016)
Figure 9 Global Rat Model Market, By Model Type
Figure 10 Global Rat Model Market, By Service
Figure 11 Global Rat Model Market, By End User
Figure 12 Global Rat Model Market, By Technology
Figure 13 Global Rat Model Market, By Care Product
Figure 14 The Asia-Pacific Rat Model Market to Witness the Highest Growth During the Forecast Period
Figure 15 Attractive Opportunities in the Global Rat Model Market
Figure 16 North America Dominated the Global Rat Care Product Market in 2016
Figure 17 The Toxicology Segment to Account for the Largest Share of the Global Rat Model Market During the Forecast Period
Figure 18 The Asia-Pacific Region to Witness the Highest Growth in the Global Rat Model Market From 2016 to 2021
Figure 19 Drivers, Restraints, Opportunities, and Challenges
Figure 20 Clinical Trials Using Rat Models, By Indication
Figure 21 Clinical Trials Using Rat Models, By Phase
Figure 22 Research Studies Using Rat Models, By Indication
Figure 23 Based on Model Type, the Outbred Rats Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 24 Based on Service, the Breeding Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 25 Rat Model Market, By Technology, 2016-2021
Figure 26 Based on Therapeutic Area, the Toxicology Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 27 Based on End User, the Pharmaceutical & Biotechnology Companies Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 28 Based on Care Product, the Cages Segment is Estimated to Dominate the Rat Care Products Market in 2016
Figure 29 North America Dominates the Market for Rat Model Products
Figure 30 North America: Rat Model Market Snapshot
Figure 31 Europe: Rat Model Market Snapshot
Figure 32 Number of Cell Therapy Preclinical Studies Listed in the U.K. Preclinical Research Database , 2013-2016
Figure 33 Asia-Pacific: Rat Model Market Snapshot
Figure 34 Rest of the World: Rat Model Market Snapshot
Figure 35 Major Players Focusing on Inorganic Growth Strategies
Figure 36 Market Share Analysis, By Key Player, 2015
Figure 37 Agreements, Collaborations, and Partnerships Was the Key Growth Strategy Adopted By Market Players
Figure 38 Agreements, Collaborations, and Partnerships, By Company (2013–2016)
Figure 39 Acquisitions, By Company (2013–2016)
Figure 40 Expansions, By Company (2013–2016)
Figure 41 New Product Launches, By Company (2013–2016)
Figure 42 Other Strategies, By Company (2013–2016)
Figure 43 Geographic Revenue Mix of Top Market Players
Figure 44 Charles River Laboratories International, Inc.: Company Snapshot
Figure 45 Laboratory Corporation of America Holdings: Company Snapshot
Figure 46 Genoway S.A.: Company Snapshot
Figure 47 Horizon Discovery Group PLC: Company Snapshot


【レポートのキーワード】

ラットモデル、ラットモデル種類、非近交系ラット、近交系ラット、ノックアウトラット、ラットモデル技術、治療分野、サービス、ケア製品、需要先

★調査レポート[ラットモデルの世界市場予測(~2021):モデル種類別(非近交系、近交系、ノックアウト)、技術別、治療分野別、サービス別、ケア製品別、需要先別] ( Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021 / MAM-BT-3682) 販売に関する免責事項
[ラットモデルの世界市場予測(~2021):モデル種類別(非近交系、近交系、ノックアウト)、技術別、治療分野別、サービス別、ケア製品別、需要先別] ( Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021 / MAM-BT-3682) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆